Attached files
| file | filename |
|---|---|
| 10-K - 10-K - Arcadia Biosciences, Inc. | rkda-10k_20171231.htm |
| EX-31.1 - EX-31.1 - Arcadia Biosciences, Inc. | rkda-ex311_8.htm |
| EX-31.2 - EX-31.2 - Arcadia Biosciences, Inc. | rkda-ex312_6.htm |
| EX-32.2 - EX-32.2 - Arcadia Biosciences, Inc. | rkda-ex322_9.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Arcadia Biosciences, Inc. (the “Company”) on Form 10-K for the year ended December 31, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
|
|
(1) |
the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
|
(2) |
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|
Date: March 20, 2018 |
By: |
/s/ RAJENDRA KETKAR |
|
|
|
Rajendra Ketkar President and Chief Executive Officer |
|
|
|
(Principal Executive Officer) |